11
Blocking myofibroblast differentiation with an anti-TGFβ antibody decreases the induction of higher-order aberrations after photorefractive keratectomy (PRK) in a cat model Bühren J, Nagy LJ, DiMagistris M, MacRae SM, Huxlin KR Advanced Physiological Optics Laboratory Department of Ophthalmology University of Rochester Medical Center Rochester, N.Y., USA

Blocking myofibroblast differentiation with an anti-TGFβ ...voi.opt.uh.edu/23_Buehren_Anti-TGF-BetaAntibody.pdf · higher-order aberrations after photorefractive keratectomy (PRK)

  • Upload
    vanphuc

  • View
    215

  • Download
    0

Embed Size (px)

Citation preview

Blocking myofibroblast differentiation with an anti-TGFβ antibody decreases the induction of higher-order aberrations after photorefractive keratectomy (PRK) in a cat model

Bühren J, Nagy LJ, DiMagistris M, MacRae SM, Huxlin KR

Advanced Physiological Optics Laboratory Department of Ophthalmology University of Rochester Medical Center Rochester, N.Y., USA

Objective

•  Wound healing can compromise the outcome of surface ablation procedures (PRK)

Objective

•  Wound healing effects can compromise the outcome of surface ablation procedures (PRK)

•  TGFβ (Transforming Growth Factor β) plays a pivotal role in corneal wound healing (esp. transformation of keratocytes into myofibroblasts)

Objective

•  Wound healing effects can compromise the outcome of surface ablation procedures (PRK)

•  TGFβ (Transforming Growth Factor β) plays a pivotal role in corneal wound healing (myofibroblast transformation)

•  Hypothesis: “Contractile myofibroblasts contribute to induction of higher order optical aberrations after PRK”

Methods: PRK in cats

•  8 eyes from 5 domestic shorthair cats (felis cattus) underwent PRK for myopia (Planoscan, B & L) -10 D, 6mm OZ

•  follow-up exams: 2, 4, 8 and 12 weeks

treatment eye: anti-TGFβ

(1mg/mL b.i.d.)

control eye: vehicle solution b.i.d.

for 7 days

Methods: aberrometry in awake-behaving cats

•  wavefront sensing (H/S sensor - 300µm lenslet spacing) in fixating cats •  Zernike decomposition (10th order)

–  LOA RMS, coma RMS, SA RMS, residual RMS –  VSOTF

Huxlin, Yoon, Nagy, Porter, Williams. Vis Res 2004;44:2159-69 Nagy, MacRae, Yoon, Cox, Huxlin , J Cat Refr Surg 2007; 33: 1051-1064 Bühren, Yoon, Kenner, MacRae, Huxlin, IOVS 2007; 48: 5806 – 5814

1 mm

Results: wavefront I (LOA)

M [D

]

time [week] 0 4 8 12

-2

0

2

4

6

8 M

J0 [D

]

time [week] 0 4 8 12

-1.0

-0.5

0

0.5

1.0 J0

J45

[D]

time [week] 0 4 8 12

-1.0

-0.5

0

0.5

1.0

J45

treatments controls

LOA: no differences

Results: wavefront II (HOA)

coma

time [week] 0 4 8 12

com

a R

MS

[µm

]

0

0.5

1.0

1.5

time [week] 0 4 8 12

SA

RM

S [µ

m] spherical

0

0.5

1.0

1.5

time [week] 0 4 8 12

resi

dual

HO

A R

MS

[µm

]

0

0.5

1.0

1.5 residual

treatments controls

C ≥2

n

C ±1

n C 0

n

Results: wavefront II (HOA)

coma

time [week] 0 4 8 12

com

a R

MS

[µm

]

0

0.5

1.0

1.5

time [week] 0 4 8 12

SA

RM

S [µ

m] spherical

0

0.5

1.0

1.5

time [week] 0 4 8 12

resi

dual

HO

A R

MS

[µm

] 0

0.5

1.0

1.5

residual

log

BC

VS

OTF

-2.0

-1.6

-1.2

-0.8

-0.4

0 BCVSOTF

time [week] 0 4 8 12

treatments controls

α-TGF treatment group: •  less coma, SA and other HOA

•  better retinal image quality •  less fluctuation

treatments controls

Conclusion

Pharmacological wound healing modulation can affect wavefront aberrations after PRK

Thank you !